APHA

Shareholders Encouraged to Visit Joint Company Website for Information About the Proposed Aphria-Tilray Combination Anti-Trust Clearances Received and Transaction Remains On-Track to Close in the Second Quarter of 2021 LEAMINGTON, ON and NANAIMO, BC, Feb. 23, 2021 - Aphria Inc. ("Aphria") (TSX: APHA andNASDAQ: APHA), a leading global cann... Read More...

Each Aphria vape is designed with a unique offering to meet the demands of a diverse consumer segment. Whether it be through limited release options, like Solei's Gather Frosty Mint or by the Company's proprietary extraction processes, 510 vapes across all brands offer a high-quality extract, free of cutting agents. "Since day one we ha... Read More...

LEAMINGTON, Ontario & CHICAGO--(BUSINESS WIRE)--Aphria Inc. (“Aphria”) (TSX: APHA and Nasdaq: APHA), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, and public relations firm Wye Communications (“Wyecomm”), today announced their collaboration. As Aphria seeks to expand t... Read More...

Pharmaceutical GMP grade QIXLEEF™ shippedOTTAWA, ON / ACCESSWIRE / September 2, 2020 / Tetra Bio-Pharma Inc. ("Tetra") (TSX:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, is pleased to announce that it has initiated the in-life phase of the clinical trial operations now that the investigational QIXLEEF... Read More...

LEAMINGTON, ON, July 6, 2020 - Aphria Inc. ("Aphria") (TSX: APHA andNASDAQ: APHA), a leading global cannabis company, today announced that it has issued 1,658,375 common shares (the "Settlement Shares") to Emblem Cannabis Corporation ("Emblem"), a wholly owned subsidiary of Aleafia Health Inc. (TSX: AH, OTC: ALEAF) ("Aleafia Health") as p... Read More...